© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Together is global

Together is global

Technology / Life Sciences

Our team has extensive experience in advising Israeli and foreign companies in the fields of biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging and more

Barnea provides a full suite of legal advisory and practical services, from the R&D stage through to the finished product, including applications for government support and the drafting of various agreements, such as clinical trial agreements with research institutes, academic institutions and hospitals.

 

The expertise of our life sciences team enables us to advise companies from the first glimmer of the concept, through all of the requisite procedures in founding the company, providing ongoing advice and legal services during the start-up of the venture and ensuring that the corporation’s structure and chosen business strategy will ensure the company’s growth.

 

Barnea represents entrepreneurs, venture capital funds, private funds and medical instrumentation companies operating in Israel and abroad.

 

Back to Technology

News and updates - Technology / Life Sciences:


July 30, 2018

Barnea Represented JJDC as the Lead Investor in OrthoSpin Ltd.

Our firm represented the US pharmaceutical and medical devices company Johnson & Johnson Development Corporation (JJDC) in a USD 3 million lead investment round in OrthoSpin Ltd. OrthoSpin is an Israeli-based startup that provides smart robotic external fixation systems.

February 1, 2018

Barnea Advised on the $703 Million Acquisition of Theramex by CVC

Barnea Advised on the $703 Million Acquisition of Theramex by CVC Capital Partners. Theramex is Teva Pharmaceutical Industries' global women’s health portfolio.

November 8, 2017

Hosting Australian Fund Bio Capital Impact

Barnea & Co. is hosting today Bio Capital Impact Fund, an Australian fund with vast experience in the BioTech, MedTech, and AgriTech industries. The representatives of the fund came to Israel to explore the possible investment in startups operating in those fields.

Technology / Life Sciences

Our team has extensive experience in advising Israeli and foreign companies in the fields of biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging and more

Barnea provides a full suite of legal advisory and practical services, from the R&D stage through to the finished product, including applications for government support and the drafting of various agreements, such as clinical trial agreements with research institutes, academic institutions and hospitals.

 

The expertise of our life sciences team enables us to advise companies from the first glimmer of the concept, through all of the requisite procedures in founding the company, providing ongoing advice and legal services during the start-up of the venture and ensuring that the corporation’s structure and chosen business strategy will ensure the company’s growth.

 

Barnea represents entrepreneurs, venture capital funds, private funds and medical instrumentation companies operating in Israel and abroad.

 

Back to Technology

News and updates - Technology:


July 30, 2018

Barnea Represented JJDC as the Lead Investor in OrthoSpin Ltd.

Our firm represented the US pharmaceutical and medical devices company Johnson & Johnson Development Corporation (JJDC) in a USD 3 million lead investment round in OrthoSpin Ltd. OrthoSpin is an Israeli-based startup that provides smart robotic external fixation systems.

February 1, 2018

Barnea Advised on the $703 Million Acquisition of Theramex by CVC

Barnea Advised on the $703 Million Acquisition of Theramex by CVC Capital Partners. Theramex is Teva Pharmaceutical Industries' global women’s health portfolio.

November 8, 2017

Hosting Australian Fund Bio Capital Impact

Barnea & Co. is hosting today Bio Capital Impact Fund, an Australian fund with vast experience in the BioTech, MedTech, and AgriTech industries. The representatives of the fund came to Israel to explore the possible investment in startups operating in those fields.

Enter your email for newsletter sign up: